Product Pathways - Transcription Factors
NRF2 (D1Z9C) XP® Rabbit mAb (PE Conjugate) #14409
|14409S||100 µl ( 50 tests )||￥4,264.00 现货查询||购买询价|
|14409||carrier free & custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: F=Flow Cytometry,
Specificity / Sensitivity
NRF2 (D1Z9C) XP® Rabbit mAb (PE Conjugate) recognizes endogenous levels of total NRF2 protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala275 of human NRF2 protein.
This Cell Signaling Technology antibody is conjugated to phycoerythrin (PE) and tested in-house for direct flow cytometry analysis in human cells. The antibody is expected to exhibit the same species cross-reactivity as the unconjugated NRF2 (D1Z9C) XP® Rabbit mAb #12721.
The nuclear factor-like 2 (NRF2) transcriptional activator binds antioxidant response elements (ARE) of target gene promoter regions to regulate expression of oxidative stress response genes. Under basal conditions, the NRF2 inhibitor INrf2 (also called KEAP1) binds and retains NRF2 in the cytoplasm where it can be targeted for ubiquitin-mediated degradation (1). Small amounts of constitutive nuclear NRF2 maintain cellular homeostasis through regulation of basal expression of antioxidant response genes. Following oxidative or electrophilic stress, KEAP1 releases NRF2, thereby allowing the activator to translocate to the nucleus and bind to ARE-containing genes (2). The coordinated action of NRF2 and other transcription factors mediates the response to oxidative stress (3). Altered expression of NRF2 is associated with chronic obstructive pulmonary disease (COPD) (4). NRF2 activity in lung cancer cell lines directly correlates with cell proliferation rates, and inhibition of NRF2 expression by siRNA enhances anti-cancer drug-induced apoptosis (5).
- Cullinan, S.B. et al. (2004) Mol Cell Biol 24, 8477-86.
- Nguyen, T. et al. (2005) J Biol Chem 280, 32485-92.
- Jaiswal, A.K. (2004) Free Radic Biol Med 36, 1199-207.
- Suzuki, M. et al. (2008) Am J Respir Cell Mol Biol 39, 673-82.
- Homma, S. et al. (2009) Clin Cancer Res 15, 3423-32.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
用户评论 --- 共 0 条